Low frequency of HLA-B27 and scarcity of ankylosing spondylitis in a Zairean Bantu population

Clinical Rheumatology

Volumn 17, Issue 4, 1998, Pages 309-310

  Mbayo, K ^a   Mbuyi Muamba, J M ^a,d   Lurhuma, A Z ^a   Halle, L ^b   Kaplan, C ^b   Dequeker, J ^c  

^a Cliniques Universitaires de Kinshasa   (Democratic Republic Congo)

^b INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d Cliniques Universitaires   (Democratic Republic Congo)

Author keywords

Ankylosing spondylitis; HLA B27; Zaire

Indexed keywords

HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; ARTICLE; DEMOCRATIC REPUBLIC CONGO; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; MALE; PREVALENCE; SPONDYLITIS, ANKYLOSING;

EID: 0031714684     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01451011     Document Type: Article

References (16)

1. Benjamin R, Parham P. Guilty by association, HLA-B27 and ankylosing spondylitis. Immunol Today 1990;11:137-42.
2. Dausset J. Implications cliniques du complexe majeur d'histocompatibilité. In: Flammarion, editor. HLA complexe majeur d'histocompatibilité de l'homme. Medecine-Sciences, 1989:298-316.
3. Sieper J, Kingsley G. Recent advances in the pathogenesis of reactive arthritis. Immunol Today 1996;17:160-3.
4. Colombani J. Implications cliniques du complexe majeur d'histocompatibilité. In: HLA fonctions immunitaires et applications cliniques. John Libbey Eurotext, 1993:231-7.
5. Mbuyi-Muamba JM, Malonda N, Yuma O. Ankylosing spondylitis in two Zairean brothers. Clin Rheumatol 1993;12:268-70.
6. Fotina M, Merson EJ, Benoit P, Rowe AW, Allen FH. Lymphocyte typing simplified microlymphocytotoxicity using frozen and thawed cells. In: Histocompatibility testing. Baltimore: Williams and Wilkins, 1967:429-32.
7. Kaplan C, Hallé L, Castellano F, D Ambrosio AM. Séparation des lymphocytes totaux par la technique du Ficoll Triosyl. In: Fiches techniques du laboratoire d'immunologie leucoplaquettaire. Paris: Institut National de Transfusion Sanguine, 1988:9-11.
8. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxine. Nature 1964;204:998-100.
9. Ceppellini R, Sinilascano M, Smith CAB. The estimation of gene frequencies in a random mating population. Ann Hum Genet 1955;20:97-115.
10. Larsen SO. A program for maximum likelihood estimation and likelihood ratio tests in one locus ABO-like systems based upon population phenotype data. Comput Progr Biomed 1979;9:213-7.
11. Tsuji K, Aizawa M, Sasazuki T. In: HLA 1991, Proceedings of the 11th International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992.
12. Dutoit ED, McGregor KJ, Taijaard DG. Oudshoorn M. HLA A, B, C, DR and DQ polymorphisms in three South African population groups: South African Negroes, Cape coloureds and South African Caucasoïds. Tissue Antigens 1987;31:109-25.
13. Okoye RC, Williams E, Alonso A, et al. HLA polymorphisms in Nigerians. Tissue Antigens 1985;25:142-55.
14. Stein M, Davis P. Rheumatic disorders in Zimbabwe: a prospective analysis of patients attending a rheumatic disease clinic. Annals of Rheumatic Diseases 1990;49;400-2.
15. Tak Yu D, Feng Huang, Wen-Chan Tsai. Pathogenic mechanism of spondyloarthropathies. Proceedings of the 19th liar Congress of Rheumatology. Singapore, p.200.
16. Brostoff J, Male D, Scadding GK, Roitt IM. Influence molécules HLA, sur les maladies. In Immunologie Clinique (traduction française) Ed. De Boeck Université, Belgique 1991:18-21.